Several of the IBD-M patients were prescribed steroids, azathioprine, mercaptopurine, or methotrexate, and 3 were treated with tofacitinib (for Sweet’s syndrome, PIK3cd, and SCAD); 25 of the 65 mimics (38.5%) were treated with biologics for presumed IBD (Table 2, Figure 2); 14 were treated with one biologic, 5 with 2 biologics, and 6 with 3 or more biologics. This evidence concerns the gene PIK3CD and inflammatory bowel disease.